Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy.
Saved in:
| Title: | Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy. |
|---|---|
| Authors: | Bleve S; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA., Arham AB; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Holmes A; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Tagawa ST; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2025 Oct; Vol. 34 (10), pp. 755-773. Date of Electronic Publication: 2025 Oct 15. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-7658 |
|---|---|
| DOI: | 10.1080/13543784.2025.2573647 |
